Verastem Oncology Competitors and Similar CompaniesClear all

Verastem Oncology's competitors and similar companies include Novartis and Mirati Therapeutics.

	Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
Founding Date	Founding Date 2010	Founding Date 1996	Founding Date 2013
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology therapy
Locations	Locations Needham, US HQ Walsrode, DE	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations San Diego, US HQ Zug, CH
Employees	Employees 7328% increase	Employees 75,883	Employees 666% decrease
Financial
Revenue (est.)	Revenue (est.) $30.9m (FY, 2025)	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) $12.4m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods $8.4b (FY, 2025)	Cost of goods $600k (FY, 2022)
Gross profit	Gross profit N/A	Gross profit $49.8b (FY, 2025)	Gross profit $11.8m (FY, 2022)
Net income	Net income ($209.5m) (FY, 2025)	Net income $14b (FY, 2025)	Net income ($740.9m) (FY, 2022)
Operating ⚠
Phase I/II Trials Products	Phase I/II Trials Products 6 (FY, 2020)	Phase I/II Trials Products 100 (FY, 2022)	Phase I/II Trials Products N/A
Funding
Total funding raised	Total funding raised $ 170m	Total funding raised $ 6.5m	Total funding raised N/A